Korsana Biosciences, Inc. SEC filings

Filings

Every filing, newest first. MAJOR and NOTABLE filings lead the app's feed; ROUTINE ones are kept here.

1. ROUTINESCHEDULE 13G/AKorsana Biosciences, Inc.KRSA3d

   Korsana Biosciences, Inc. (CYCN) reports 0.1% ownership

   • 0.1% ownership by J. Wood Capital Advisors LLC
   • 25,974 shares beneficially owned
   • Filing date: 2026-10-15

   J. WOOD CAPITAL ADVISORS LLC, filed by

2. ROUTINEDEF 14AKorsana Biosciences, Inc.KRSA3d

   Korsana Biosciences to resubmit redomestication

   • Special meeting on Nov 13, 2026
   • Merger completed on Sep 8, 2026
   • Redomestication failed in Aug 2026
3. ROUTINESCHEDULE 13G/AKorsana Biosciences, Inc.KRSAOct 8

   Korsana Biosciences Inc shares held by FMR LLC

   • FMR LLC owns 3,144,797 shares
   • 6.9% of total shares
   • Abigail P. Johnson also owns 3,144,797 shares

   FMR LLC, filed by

4. ROUTINEPRE 14AKorsana Biosciences, Inc.KRSAOct 5

   Korsana Biosciences resubmits redomestication

   • Filed PRE 14A on 2026-10-05
   • Special meeting on 2026-11-13
   • Redomestication failed in August 2026
5. ROUTINE144Korsana Biosciences, Inc.KRSASep 23

   Errol B Desouza, planned sale of KRSA shares

   Errol B Desouza, reporting

6. ROUTINE144Korsana Biosciences, Inc.KRSASep 22

   Errol B Desouza, planned sale of KRSA shares

   Errol B Desouza, reporting

7. ROUTINESCHEDULE 13GKorsana Biosciences, Inc.KRSASep 21

   Ownership stake disclosure by GENERAL ATLANTIC, L.P.

   GENERAL ATLANTIC, L.P., filed by

8. ROUTINE144Korsana Biosciences, Inc.KRSASep 18

   Errol B Desouza, planned sale of KRSA shares

   Errol B Desouza, reporting

9. ROUTINESCHEDULE 13GKorsana Biosciences, Inc.KRSASep 16

   Ownership stake disclosure by Wellington Biomedical Innovation Master Investors (Cayman) II L.P.

   Wellington Biomedical Innovation Master Investors (Cayman) II L.P., filed by

10. NOTABLESCHEDULE 13DKorsana Biosciences, Inc.KRSASep 15

    Ownership stake disclosure by Venrock Healthcare Capital Partners III, L.P.

    Venrock Healthcare Capital Partners III, L.P., filed by

11. NOTABLESCHEDULE 13DKorsana Biosciences, Inc.CYCNSep 11

    Ownership stake disclosure by Fairmount Funds Management LLC

    Fairmount Funds Management LLC, filed by

12. ROUTINE8-KKorsana Biosciences, Inc.CYCNSep 11

    Current report

13. ROUTINE4Korsana Biosciences, Inc.CYCNSep 10

    12 insider filings

    Michelle Patricia Pernice, insider filing for CYCN

    Show all 12

    • 4Insider filing for CYCNSep 10
    • 4Insider filing for CYCNSep 10
    • 4Insider filing for CYCNSep 10
    • 4Insider filing for CYCNSep 10
    • 3New insider at CYCNSep 10
    • 3New insider at CYCNSep 10
    • 3New insider at CYCNSep 10
    • 3New insider at CYCNSep 10
    • 3New insider at CYCNSep 10
    • 3New insider at CYCNSep 10
    • 3New insider at CYCNSep 10
    • 3New insider at CYCNSep 10

    Michelle Patricia Pernice, reporting

14. ROUTINE8-KCyclerion Therapeutics, Inc.CYCNAug 27

    Current report

15. ROUTINE425Cyclerion Therapeutics, Inc.CYCNAug 25

    Merger communication

16. ROUTINE8-KCyclerion Therapeutics, Inc.CYCNAug 25

    Current report

17. ROUTINE4Cyclerion Therapeutics, Inc.CYCNAug 18

    2 insider filings

    Rhonda M. Chicko, insider filing for CYCN

    Show all 2

    • 4Insider filing for CYCNAug 18
    • 4Insider filing for CYCNAug 18

    Rhonda M. Chicko, reporting

18. ROUTINESCHEDULE 13GCyclerion Therapeutics, Inc.CYCNAug 14

    Ownership stake disclosure by ADAR1 Capital Management, LLC

    ADAR1 Capital Management, LLC, filed by

19. ROUTINESCHEDULE 13GCyclerion Therapeutics, Inc.CYCNAug 14

    Ownership stake disclosure by BALYASNY ASSET MANAGEMENT L.P.

    BALYASNY ASSET MANAGEMENT L.P., filed by

20. ROUTINE425Cyclerion Therapeutics, Inc.CYCNAug 12

    Merger communication

21. ROUTINE425Cyclerion Therapeutics, Inc.CYCNAug 10

    Merger communication

22. ROUTINE425Cyclerion Therapeutics, Inc.CYCNAug 6

    Merger communication

23. NOTABLE10-QCyclerion Therapeutics, Inc.CYCNAug 4

    Quarterly report

24. ROUTINE425Cyclerion Therapeutics, Inc.CYCNAug 3

    Merger communication

25. ROUTINEEFFECTCyclerion Therapeutics, Inc.CYCNJul 27

    Registration declared effective

26. ROUTINE424B3Cyclerion Therapeutics, Inc.CYCNJul 24

    Securities offering

27. ROUTINES-4/ACyclerion Therapeutics, Inc.CYCNJul 22

    Merger registration (amended)

28. NOTABLESCHEDULE 13D/ACyclerion Therapeutics, Inc.CYCNJul 20

    Ownership stake disclosure by Peter M Hecht (amended)

    Peter M Hecht, filed by

29. ROUTINE4Cyclerion Therapeutics, Inc.CYCNJul 20

    Peter M Hecht, insider filing for CYCN

    Peter M Hecht, reporting

30. ROUTINE425Cyclerion Therapeutics, Inc.CYCNJul 10

    Merger communication

31. ROUTINES-4/ACyclerion Therapeutics, Inc.CYCNJun 9

    Merger registration (amended)

32. NOTABLE10-QCyclerion Therapeutics, Inc.CYCNMay 12

    Quarterly report

33. ROUTINESCHEDULE 13GCyclerion Therapeutics, Inc.CYCNMay 7

    Ownership stake disclosure by FMR LLC

    FMR LLC, filed by

34. ROUTINE10-K/ACyclerion Therapeutics, Inc.CYCNApr 30

    Annual report (amended)

35. NOTABLES-4Cyclerion Therapeutics, Inc.CYCNApr 20

    Merger registration

36. ROUTINE425Cyclerion Therapeutics, Inc.CYCNApr 1

    Merger communication

37. ROUTINE8-KCyclerion Therapeutics, Inc.CYCNApr 1

    Current report

38. ROUTINE8-KCyclerion Therapeutics, Inc.CYCNFeb 17

    Current report

Older filings on EDGAR